Understanding Secondary Hypercoagulable State: Find information on diagnosis, clinical documentation, and medical coding for this condition. Explore resources for healthcare professionals, including ICD-10 codes, treatment options, and risk factors associated with acquired thrombophilia. Learn about laboratory testing, differential diagnosis, and best practices for managing secondary hypercoagulable states in clinical settings. This resource offers guidance on proper documentation and coding to ensure accurate billing and reimbursement.
Also known as
Other specified coagulation defects
Covers secondary hypercoagulability not elsewhere classified.
Disorders of coagulation
Includes various coagulation abnormalities, some causing hypercoagulability.
Other venous embolism and thrombosis
Conditions associated with or resulting from hypercoagulable states.
Hypercoagulable state with recurrent venous thrombosis
Specific type of hypercoagulability with repeated venous thrombosis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the hypercoagulable state secondary to a known condition?
When to use each related code
| Description |
|---|
| Secondary Hypercoagulability |
| Antiphospholipid Syndrome |
| Factor V Leiden |
Coding D68.59 without documenting the specific cause of the secondary hypercoagulable state leads to inaccurate risk adjustment and potential denials.
Failure to code the underlying malignancy or other condition causing the hypercoagulable state impacts severity scores and reimbursement.
Incorrectly coding an acquired hypercoagulable state as inherited (e.g., Factor V Leiden) or vice-versa leads to inaccurate clinical documentation and coding errors.
Patient presents with suspected secondary hypercoagulable state. Presenting symptoms include [specific symptoms, e.g., recurrent deep vein thrombosis, pulmonary embolism, unexplained thrombotic events, recurrent pregnancy loss]. Patient history is significant for [relevant medical history, e.g., malignancy, recent surgery, trauma, immobilization, inflammatory condition, oral contraceptive use, hormone replacement therapy, pregnancy, antiphospholipid syndrome, nephrotic syndrome, paroxysmal nocturnal hemoglobinuria]. Physical examination reveals [relevant physical findings, e.g., edema, erythema, tenderness along the affected vein, diminished pulses, shortness of breath, chest pain]. Differential diagnosis includes [other possible diagnoses, e.g., inherited thrombophilia, factor V Leiden, prothrombin gene mutation, protein C or S deficiency, antithrombin deficiency]. Diagnostic workup may include [relevant diagnostic tests, e.g., D-dimer, coagulation studies PT, PTT, INR, complete blood count, Doppler ultrasound, CT angiography, VQ scan, thrombophilia screening]. Pre-existing conditions contributing to the hypercoagulable state are [list pre-existing conditions]. Assessment suggests a secondary hypercoagulable state likely secondary to [underlying cause]. Plan of care includes [treatment plan, e.g., anticoagulation therapy with heparin, warfarin, or direct oral anticoagulants DOACs, management of underlying condition, lifestyle modifications including smoking cessation and increased physical activity]. Patient education provided on the importance of medication adherence, follow-up appointments, and signs and symptoms of bleeding and thromboembolic complications. ICD-10 code [relevant ICD-10 code, e.g., D68.8 Other specified coagulation defects] is considered. Continued monitoring and reassessment will be necessary to optimize treatment and minimize risk of thrombotic recurrence.